TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML December 28, 2007
TCL Archive Senate Committee Ok’s $1.9 Billion Budget For NCI, Same As House Appropriation July 29, 1994
TCL Archive Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials March 28, 1986
